{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:09:15Z","timestamp":1789189755547,"version":"build-2803163510"},"reference-count":48,"publisher":"Japan Atherosclerosis Society","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5551\/jat.66254","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:11:34Z","timestamp":1788819094000},"source":"Crossref","is-referenced-by-count":0,"title":["Cholesterol Metabolism Regulation by Native and Oxidized Low-Density Lipoprotein in a Liver Cell Line"],"prefix":"10.5551","author":[{"given":"Nakyoung","family":"Kim","sequence":"first","affiliation":[{"name":"Faculty of Health Sciences, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himeno","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanao","family":"Murakami","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iku","family":"Sazaki","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ping","family":"Hui","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Shin S, Kim J, Lee JY, Kim J, and Oh CM: Mitochondrial quality control: its role in metabolic dysfunction-associated steatotic liver disease (MASLD). J Obes Metab Syndr, 2023; 32: 289-302","DOI":"10.7570\/jomes23054"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Miao L, Targher G, Byrne CD, Cao YY, and Zheng MH: Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab, 2024; 35: 697-707","DOI":"10.1016\/j.tem.2024.02.007"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Younossi ZM, Kalligeros M, and Henry L: Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol, 2025; 31: S32-S50","DOI":"10.3350\/cmh.2024.0431"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Fazel Y, Koenig AB, Sayiner M, Goodman ZD, and Younossi ZM: Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism, 2016; 65: 1017-1025","DOI":"10.1016\/j.metabol.2016.01.012"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tomeno W, Imajo K, Takayanagi T, Ebisawa Y, Seita K, Takimoto T, Honda K, Kobayashi T, Nogami A, Kato T, Honda Y, Kessoku T, Ogawa Y, Kirikoshi H, Sakamoto Y, Yoneda M, Saito S, and Nakajima A: Complications of non-alcoholic fatty liver disease in extrahepatic Organs. Diagnostics (Basel), 2020; 10: 912","DOI":"10.3390\/diagnostics10110912"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Matsumori R, Tanaka M, Sato T, Akiyama Y, Hosaka I, Nakata K, Kawaharata W, Aida H, Nishizawa K, Kouzu H, Yama N, Hanawa N, and Furuhashi M: An apparent association of metabolic dysfunction-associated steatotic liver disease with high levels of estimated small dense LDL cholesterol in a Japanese population. J Atheroscler Thromb, 2025; 32: 65939","DOI":"10.5551\/jat.65939"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tribble DL, Rizzo M, Chait A, Lewis DM, Blanche PJ, and Krauss RM: Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. Am J Med, 2001; 110: 103-110","DOI":"10.1016\/S0002-9343(00)00700-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yimin FH, Furumaki H, Matsuoka S, Sakurai T, Kohanawa M, Zhao S, Kuge Y, Tamaki N, Chiba H: A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein. Lab Invest, 2012; 92: 265-281","DOI":"10.1038\/labinvest.2011.159"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Liscum L and Munn NJ: Intracellular cholesterol transport. Biochim Biophys Acta, 1999; 1438: 19-37","DOI":"10.1016\/S1388-1981(99)00043-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Goldstein JL and Brown MS: The LDL receptor. Arterioscler Thromb Vasc Biol, 2009; 29: 431-438","DOI":"10.1161\/ATVBAHA.108.179564"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Luo J, Yang H, and Song BL: Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol, 2020; 21: 225-245","DOI":"10.1038\/s41580-019-0190-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Brown MS and Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science, 1986; 232: 34-47","DOI":"10.1126\/science.3513311"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Lagace TA, Curtis DE, Garuti R, McNutt MC, Park SW, Prather HB, Anderson NN, Ho YK, Hammer RE, and Horton JD: Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. J Clin Invest, 2006; 116: 2995-3005","DOI":"10.1172\/JCI29383"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Lebeau PF, Byun JH, Platko K, Al-Hashimi AA, Lhot\u00e1k \u0160, MacDonald ME, Mejia-Benitez A, Igdoura SA, Trigatti B, Maclean KN, Seidah NG, and Austin: RC: Pcsk9 knockout exacerbates diet-induced non-alcoholic steatohepatitis, fibrosis and liver injury in mice. JHEP Rep, 2019; 1: 418-429","DOI":"10.1016\/j.jhepr.2019.10.009"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Shafiq M, Walmann T, Nutalapati V, Gibson C, and Zafar Y: Effects of proprotein convertase subtilisin\/kexin type-9 inhibitors on fatty liver. World J Hepatol, 2020; 12: 1258-1266","DOI":"10.4254\/wjh.v12.i12.1258"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Sazaki I, Sakurai T, Yamahata A, Mogi S, Inoue N, Ishida K, Kikkai A, Takeshita H, Sakurai A, Takahashi Y, Chiba H, and Hui SP: Oxidized low-density lipoproteins trigger hepatocellular oxidative stress with the formation of cholesteryl ester hydroperoxide-enriched lipid droplets. Int J Mol Sci, 2023; 24: 4281","DOI":"10.3390\/ijms24054281"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Bellanti F, Villani R, Facciorusso A, Vendemiale G, and Serviddio G: Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis. Free Radic Biol Med, 2017; 111: 173-185","DOI":"10.1016\/j.freeradbiomed.2017.01.023"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wei Y, Wang D, Topczewski F, and Pagliassotti MJ: Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab, 2006; 291: E275-E281","DOI":"10.1152\/ajpendo.00644.2005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ikuta A, Sakurai T, Nishimukai M, Takahashi Y, Nagasaka A, Hui SP, Hara H, and Chiba H: Composition of plasmalogens in serum lipoproteins from patients with non-alcoholic steatohepatitis and their susceptibility to oxidation. Clin Chim Acta, 2019; 493: 1-7","DOI":"10.1016\/j.cca.2019.02.020"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Markwell MA, Haas SM, Bieber LL, and Tolbert NE: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem, 1978; 87: 206-210","DOI":"10.1016\/0003-2697(78)90586-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hui SP, Taguchi Y, Takeda S, Ohkawa F, Sakurai T, Yamaki S, Jin S, Fuda H, Kurosawa T, and Chiba H: Quantitative determination of phosphatidylcholine hydroperoxides during copper oxidation of LDL and HDL by liquid chromatography\/mass spectrometry. Anal Bioanal Chem, 2012; 403: 1831-1840","DOI":"10.1007\/s00216-012-5833-x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Takeda S, Subagyo A, Hui SP, Fuda H, Shrestha R, Sueoka K, and Chiba H: Elastic modulus of low-density lipoprotein as potential indicator of its oxidation. Ann Clin Biochem, 2015; 52: 647-653","DOI":"10.1177\/0004563215584958"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Folch J, Lees M, and Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem, 1957; 226: 497-509","DOI":"10.1016\/S0021-9258(18)64849-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Hara A and Radin NS: Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem, 1978; 90: 420-426","DOI":"10.1016\/0003-2697(78)90046-5"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Sud M, Fahy E, Cotter D, Brown A, Dennis EA, Glass CK, Merrill AH Jr, Murphy RC, Raetz CR, Russell DW, and Subramaniam S: LMSD: LIPID MAPS structure database. Nucleic Acids Res, 2007; 35: D527-D532","DOI":"10.1093\/nar\/gkl838"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Wu Y, Chen Z, Fuda H, Tsukui T, Wu X, Shen N, Saito N, Chiba H, and Hui SP: Oxidative stress linked organ lipid hydroperoxidation and dysregulation in mouse model of nonalcoholic steatohepatitis: revealed by lipidomic profiling of liver and kidney. Antioxidants (Basel), 2021; 10: 1602","DOI":"10.3390\/antiox10101602"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Brown MS, Dana SE, Goldstein JL: Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein. Proc Natl Acad Sci U S A, 1975; 72: 2925-2929","DOI":"10.1073\/pnas.72.8.2925"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Palomurto S, Virtanen KA, K\u00e4rj\u00e4 V, Schwab U, Kaminska D, K\u00e4kel\u00e4 P, Pihlajam\u00e4ki J, and M\u00e4nnist\u00f6 V: Metabolic dysfunction-associated steatotic liver disease alters fatty acid profiles in the liver and adipose tissue. J Clin Endocrinol Metab, 2025; 111: e23-e31","DOI":"10.1210\/clinem\/dgaf346"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Girotti AW: Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res, 1998; 39: 1529-1542","DOI":"10.1016\/S0022-2275(20)32182-9"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Karten B, Boechzelt H, Abuja PM, Mittelbach M, and Sattler W: Macrophage-enhanced formation of cholesteryl ester-core aldehydes during oxidation of low density lipoprotein. J Lipid Res, 1999; 40: 1240-1253","DOI":"10.1016\/S0022-2275(20)33486-6"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Jeong HJ, Lee HS, Kim KS, Kim YK, Yoon D, and Park SW: Sterol-dependent regulation of proprotein convertase subtilisin\/kexin type 9 expression by sterol-regulatory element binding protein-2. J Lipid Res, 2008; 49: 399-409","DOI":"10.1194\/jlr.M700443-JLR200"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Brown MS and Goldstein JL: The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell, 1997; 89: 331-340","DOI":"10.1016\/S0092-8674(00)80213-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Levitan I, Volkov S, and Subbaiah PV: Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxid Redox Signal, 2010; 13: 39-75","DOI":"10.1089\/ars.2009.2733"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Wang K, Sun C, Zhuang H, Jiang XC, and Chen Y: AFM reveals differential effects of acidification on LDL- and oxidized LDL-receptor interactions: biomechanical implications in atherogenesis. Cell Mol Biol Lett, 2025; 30: 32","DOI":"10.1186\/s11658-025-00715-9"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Ghosh S: Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization. Expert Rev Cardiovasc Ther, 2011; 9: 329-340","DOI":"10.1586\/erc.11.16"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Truong TQ, Brodeur MR, Falstrault L, Rhainds D, and Brissette L: Expression of caveolin-1 in hepatic cells increases oxidized LDL uptake and preserves the expression of lipoprotein receptors. J Cell Biochem, 2009; 108: 906-915","DOI":"10.1002\/jcb.22321"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Maler\u00f8d L, Juvet LK, Hanssen-Bauer A, Eskild W, Berg T: Oxysterol-activated LXRalpha\/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochem Biophys Res Commun, 2002; 299: 916-923","DOI":"10.1016\/S0006-291X(02)02760-2"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Back SS, Kim J, Choi D, Lee ES, Choi SY, and Han K: Cooperative transcriptional activation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 genes by nuclear receptors including Liver-X-Receptor. BMB Rep, 2013; 46: 322-327","DOI":"10.5483\/BMBRep.2013.46.6.246"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Schmitz G and Langmann T: Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim Biophys Acta, 2005; 1735: 1-19","DOI":"10.1016\/j.bbalip.2005.04.004"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Croom E: Metabolism of xenobiotics of human environments. Prog Mol Biol Transl Sci, 2012: Chapter Three; 112: 31-88","DOI":"10.1016\/B978-0-12-415813-9.00003-9"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Zhu K, Meng Q, Zhang Z, Yi T, He Y, Zheng J, and Lei W: Aryl hydrocarbon receptor pathway: role, regulation and intervention in atherosclerosis therapy (Review). Mol Med Rep, 2019; 20: 4763-4773","DOI":"10.3892\/mmr.2019.10748"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Mathieu MC, Lapierre I, Brault K, and Raymond M: Aromatic hydrocarbon receptor (AhR). AhR nuclear translocator- and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma cells. J Biol Chem, 2001; 276: 4819-4827","DOI":"10.1074\/jbc.M008495200"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Maher JM, Cheng X, Slitt AL, Dieter MZ, and Klaassen CD: Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab Dispos, 2005; 33: 956-962","DOI":"10.1124\/dmd.105.003798"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Ji B, Ito K, Suzuki H, Sugiyama Y, and Horie T: Multidrug resistance-associated protein2 (MRP2) plays an important role in the biliary excretion of glutathione conjugates of 4-hydroxynonenal. Free Radic Biol Med, 2002; 33: 370-378","DOI":"10.1016\/S0891-5849(02)00906-1"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Li Y, Zhao T, Li J, Xia M, Li Y, Wang X, Liu C, Zheng T, Chen R, Kan D, Xie Y, Song J, Feng Y, Yu T, and Sun P: Oxidative stress and 4-hydroxy-2-nonenal (4-HNE): implications in the pathogenesis and treatment of aging-related diseases. J Immunol Res, 2022; 2022: 2233906","DOI":"10.1155\/2022\/2233906"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Ji B, Ito K, and Horie T: Multidrug resistance-associated protein 2 (MRP2) enhances 4-hydroxynonenal-induced toxicity in Madin-Darby canine kidney II cells. Chem Res Toxicol, 2004; 17: 158-164","DOI":"10.1021\/tx034067m"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Yancey PG and Jerome WG: Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux. J Lipid Res, 2001; 42: 317-327","DOI":"10.1016\/S0022-2275(20)31654-0"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Jerome WG, Cox BE, Griffin EE, and Ullery JC: Lysosomal cholesterol accumulation inhibits subsequent hydrolysis of lipoprotein cholesteryl ester. Microsc Microanal, 2008; 14: 138-149","DOI":"10.1017\/S1431927608080069"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/advpub\/0\/advpub_66254\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:42:16Z","timestamp":1789188136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/advpub\/0\/advpub_66254\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":48,"URL":"https:\/\/doi.org\/10.5551\/jat.66254","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"66254"}}